References
- Lopez G. America’s huge problem with opioid prescribing, in one quote. Vox; 2017 Sep 18 [accessed 2017 Oct 16]. Available from: https://www.vox.com/science-and-health/2017/9/18/16326816/opioid-epidemic-keith-humphreys
- Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse, and treatment in the United States: an update. Am J Psychiatry. 2016;173:18–26.
- Fox CD, Berger D, Fine PG, et al. Pain assessment and treatment in the managed care environment. A position statement from the American Pain Society. Glenview (IL): American Pain Society; 2000. p. 1–4.
- McCarberg BH. Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion. Postgrad Med. 2011;123:119–130.
- Phillips DM. JCAHO pain management standards are unveiled. JAMA. 2000;284:428–429.
- Kuehn BM. Opioid prescriptions soar. JAMA. 2007;297:249–251.
- Morone NE, Weiner DK. Pain as the fifth vital sign: exposing the vital need for pain education. Clin Ther. 2013;35:1728–1732.
- 106 Cong. Rec. S3163 (Introduced Sen. Hatch); 2000 Oct 5 [accessed 2017 May 15] Available from: https://www.congress.gov/bill/106th-congress/senate-bill/3163
- Joint Commission on Accreditation of Healthcare Organizations. Pain Standards for 2001. Joint Commission on Accreditation of Healthcare Organizations; 2001 Dec [accessed 2017 May 15]. Available from: https://www.jointcommission.org/assets/1/6/2001_Pain_Standards.pdf
- Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50); 2015. Available from: http://www.samhsa.gov/data/
- Centers for Disease C, Prevention. Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–1492.
- Johnston LD, O’Malley PM, Bachman JG, et al. Monitoring the future national survey results on drug use, 1975–2005: volume I, secondary school students (NIH Publication No. 06-5883). Bethesda (MD): National Institute on Drug Abuse;2006.
- Center for Behavioral Health Statistics and Quality. 2015 national survey on drug use and health public use file codebook. Rockville (MD): Substance Abuse and Mental Health Services Administration; 2016.
- Jones CM, Paulozzi LJ, Mack KA. Sources of prescription opioid pain relievers by frequency of past-year nonmedical use United States, 2008–2011. JAMA Intern Med. 2014;174:802–803.
- Birnbaum H, White A, Schiller M, et al. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657–667.
- Eric Holder. Remarks as prepared for delivery by Attorney General Eric Holder at the Operation Pill Nation II announcement. The United States Department of Justice; 2011 Oct [accessed 2017 May 15]. Available from: http://www.justice.gov/usao/flm/press/2011/oct/20111028_Pill%20Nation%202_AG_Remarks.pdf
- Coalition Against Insurance Fraud. Prescription for peril: how insurance fraud finances theft and abuse of addictive prescription drugs. Coalition Against Insurance Fraud; 2007 Dec [accessed 2017 Apr 17]. Available from: http://www.insurancefraud.org/downloads/drugDiversion.pdf
- Drug Enforcement Administration. Schedules of controlled substances: rescheduling of hydrocodone combination products from schedule III to schedule II. 21 CFR part 1308 [docket no. DEA 389] final rule. Fed Regist. 2014;79:49661–49682.
- Drug Enforcement Administration. Drugs of abuse: a DEA resource guide 2017 edition. U.S. Department of Justice: Drug Enforcement Administration; 2017 [accessed 2017 Oct 20]. Available from: https://www.dea.gov/pr/multimedia-library/publications/drug_of_abuse.pdf#page=8
- Cutler DM, Anderson NB, Bulatao RA, Cohen B, eds. Critical perspectives on racial and ethnic differences in health in late life. Washington (DC): National Academy Press; 2004.
- Census.gov. State intercensal tables: 2000–2010. 2016 [accessed 2018 Dec 8]. Available from: https://www.census.gov/data/tables/time-series/demo/popest/intercensal-2000-2010-state.html
- Factfinder.census.gov. American FactFinder. 2018 [Accessed 8 Dec. 2018]. Available from: https://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml?#
- Jones CM, Lurie PG, Throckmorton DC. Effect of US Drug Enforcement Administration's rescheduling of hydrocodone combination analgesic products on opioid analgesic prescribing. JAMA Intern Med. 2016;176:399–402.
- Hahn KL. Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs. Am Health Drug Benefits. 2011;4:107–114.
- Freeman PR, Goodin A, Troske S, et al. J Kentucky House Bill 1 impact evaluation. 2015 [accessed 2018 Jan 26]. Available from: http://www.khpi.org/dwnlds/2015/KentuckyHB1ImpactStudyReport03262015.pdf
- Johnson H, Paulozzi L, Porucznik C, et al. Decline in drug overdose deaths after state policy changes - Florida, 2010–2012. MMWR Morb Mortal Wkly Rep. 2014;63:569–574.
- Haider A, Zhukovsky DS, Meng YC, et al. Opioid prescription trends among cancer referred to outpatient palliative care over a 6-year period. J Oncol Pract. 2017;13:e972–e981.
- Seago S, Hayek A, Pruszynski J, et al. Chang in prescription habits after federal rescheduling of hydrocodone combination products. Proc (Bayl Univ Med Cent). 2016;29:268–270.
- Mort J, Kuschel L. Impact of the hydrocodone schedule change on opioid prescription patterns in South Dakota. Res Social Adm Pharm. 2016;12:e6.
- Schultz S, Chamberlain C, Vulcan M, et al. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. J Opioid Manag. 2016;12:119–122.
- Guidelines for prescribing controlled substances for pain. Medical Board of California; 2014 [accessed 2018 Dec 7]. Available from: http://www.mbc.ca.gov/Licensees/Prescribing/Pain_Guidelines.pdf
- Controlled Substance Utilization, Review and Evaluation System (CURES) and Controlled Substance Prescriptions - California State Board of Pharmacy. Pharmacy.ca.gov; 2016 [accessed 2018 Dec 7]. Available from: https://www.pharmacy.ca.gov/licensees/cures.shtml
- Bayó E. Prescribing laws and rules for Florida licensed physicians. Florida Medical Association; 2017 [accessed 2018 Dec 7]. Available from: https://www.flmedical.org/florida/Florida_Public/Docs/EDU/CME/CME_01-04-Bayo_Prescribing.pdf
- Health.ny.gov. BNE update. 2013 [accessed 2018 Dec 5]. Available from: https://www.health.ny.gov/professionals/narcotic/newsletters/docs/update_newsletter_spring_2013.pdf
- Guideline Resources. Drug Overdose. CDC Injury Center. cdc.gov; 2017 [accessed 2018 Dec 7]. Available from: https://www.cdc.gov/drugoverdose/prescribing/resources.html
- Morden NE, Munson JC, Colla CH, et al. Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation. Med Care. 2014;52:852–859.
- Meara E, Horwitz JR, Powell W, et al. State legal restrictions and prescription-opioid use among disabled adults. N Engl J Med. 2016;375:44–53.
- Haynes A, Kleinschmidt K, Forrester MB, et al. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone. Clin Toxicol. 2016;54:434–440.
- Sullivan MD, Bauer AM, Fulton-Kehoe D, et al. Trends in opioid dosing among Washington State Medicaid patients before and after opioid dosing guideline implementation. J Pain. 2016;17:561–568.
- Garg RK, Fulton-Kehoe D, Turner JA, et al. Changes in opioid prescribing for Washington workers’ compensation claimants after implementation of an opioid dosing guideline for chronic noncancer pain: 2004–2010. J Pain. 2013;14:1620–1628.
- Onishi E, Kobayashi T, Dexter E, et al. Comparison of opioid prescribing patterns in the United States and Japan: Primary Care Physicians’ attitudes and perceptions. J Am Board Fam Med. 2017;30:248–254.
- García MC, Dodek AB, Kowalski T, et al. Declines in opioid prescribing after a private insurer policy change — Massachusetts, 2011–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1125–1131.
- Hannan EL, Kilburn H, Racz M, et al. Improving the outcomes of coronary artery bypass surgery in New York State. JAMA. 1994;271:761–766.
- Harlan BJ. Statewide reporting of coronary artery surgery results: a view from California. J Thorac Cardiovasc Surg. 2001;121:409–417.
- Wennberg J, Blowers L, Parker R, et al. Changes in tonsillectomy rates associated with feedback and review. Pediatrics. 1977;59:821–826.